Page last updated: 2024-11-03

ritanserin and Marasmus

ritanserin has been researched along with Marasmus in 2 studies

Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Almeida, SS2
de Oliveira, LM2
Graeff, FG2

Other Studies

2 other studies available for ritanserin and Marasmus

ArticleYear
Early life protein malnutrition changes exploration of the elevated plus-maze and reactivity to anxiolytics.
    Psychopharmacology, 1991, Volume: 103, Issue:4

    Topics: Animals; Anti-Anxiety Agents; Anxiety; Diazepam; Dose-Response Relationship, Drug; Exploratory Behav

1991
Decreased reactivity to anxiolytics caused by early protein malnutrition in rats.
    Pharmacology, biochemistry, and behavior, 1990, Volume: 36, Issue:4

    Topics: Animals; Anti-Anxiety Agents; Body Weight; Diazepam; Diet; Dose-Response Relationship, Drug; Hyperto

1990